Please do not send any confidential information to us. By clicking “Accept,” you acknowledge and agree that our review of the information in your email and any attachments does not establish an attorney-client relationship between you and our firm or any of our attorneys, and does not preclude our representation of other persons/parties in matters where the information is pertinent, even if the information is highly confidential or could be exploited to your disadvantage, or you submitted it in good faith to retain us.
This website uses cookies to improve your browsing experience. By continuing to use this website you agree to our use of cookies. For more information on our use of cookies, click here to review the Cookies Policy.。
Ching-hua's practice covers a broad range of capital markets, corporate and finance matters. She has an extensive track record advising clients on their offerings of securities, including convertible or exchangeable bonds (including Hon Hai Foxconn, Formosa Plastics, Asia Cement, Ennoconn), American or Global depositary receipts (such as TSMC, AUO, Cathay Financial Holdings, Chailease Holding, TPK, Inotera, Parade, Oneness Biotech, etc.), Taiwan depositary receipts (Want Want China Holding, Super Coffee Group), supra notes or Formosa bonds (CABEI, CIBC, Natixis). Ching-hua is an experienced advisor on IPO transactions, having participated in Haidilao's Hong Kong IPO, ChipMOS Bermuda's US IPO, and Cayman company Crown Bioscience's Taiwan IPO. Recent milestone transactions that she has represented clients include reverse triangular merger between Pegatron and Casetek, privatization of TCC International Holdings, and ChipMOS' merger with offshore company with ADRs as merger consideration.
學歷
LL.M., University of Illinois at Urbana-Champaign (1999)
LL.B., National Taiwan University (1992)
